Search results
Showing 166 to 180 of 187 results for prostate cancer
Discontinued Reference number: GID-TA11252
This guidance has been updated and replaced by NICE technology appraisal guidance 1110.
This guidance has been updated and replaced by NICE technology appraisal guidance 887.
This appraisal has been withdrawn. This is because the marketing authorisation for sipuleucel-T was withdrawn on 19 May 2015.
Discontinued Reference number: GID-TA11163
We have moved interventional procedures guidance 174 to become HealthTech guidance 113. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
This guidance has been updated and replaced by NICE technology appraisal guidance 391.
Read biographies of the members of our quality standards advisory committee.
Read biographies of the members of our quality standards advisory committee.
This guidance has been updated and replaced by NICE guideline CG175.
This guideline covers preventing and managing foot problems in children, young people and adults with diabetes. It aims to reduce variation in practice, including antibiotic prescribing for diabetic foot infections.
Discontinued Reference number: GID-TA10929
In development Reference number: GID-TA11443 Expected publication date: TBC
NICE has developed a medtech innovation briefing (MIB) on the S-Cath System for suprapubic catheterisations
This manual explains the processes and methods used to develop and update NICE guidelines, the guidance that NICE develops covering topics across clinical care (in primary, secondary and community care settings), social care and public health. For more information on the other types of NICE guidance and advice (including technology appraisal guidance), see about NICE